CORCEPT THERAPEUTICS INC — Director's Dealing 2021

Jul 14, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CORCEPT THERAPEUTICS INC (CORT)
CIK: 0001088856
Period of Report: 2021-07-13

Reporting Person: Maduck Sean (Chief Commercial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-07-13	Common Stock	M	10000	$2.24	Acquired	40024	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-07-13	Stock Option (Right to Buy)	$2.24	M	10000	Disposed	2022-11-01	Common Stock (10000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	10000	Indirect
Common Stock	10000	Indirect

Footnotes

F1: Represents the shares held by Duckhill Capital, LLC of which the reporting person is President and disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein.

F2: Represents the shares held by Sean and Molly Maduck Living Trust of which the reporting person is a co-trustee.

F3: Fully exercisable.